ALLEL

Allele Biotechnology and Pharmaceuticals is a private San Diego biotechnology company focused on induced pluripotent stem cell (iPSC) technologies, cell sources, and iPSC-centered CDMO services for therapeutic developers. The company supplies clinical-grade iPSC lines, genome editing and differentiation capabilities, and cGMP manufacturing support intended to accelerate cell therapy and regenerative medicine programs. Allele also highlights proprietary mRNA reprogramming and master gene mRNA approaches for creating and scaling clinically relevant cell types. In 2026, the company announced participation with UC San Diego in an ARPA-H-supported effort to develop patient-specific 3D bioprinted livers, underscoring its emphasis on translational stem cell manufacturing rather than a conventional internal drug pipeline. Overall, Allele appears best characterized as a platform and services company serving biotech and pharma partners in immuno-oncology and regenerative medicine.